Cleared Traditional

K993612 - BINDAZYME ANTI-TISSUE TRANSGLUTAMINASE IGA EIA (FDA 510(k) Clearance)

Dec 1999
Decision
57d
Days
Class 2
Risk

K993612 is an FDA 510(k) clearance for the BINDAZYME ANTI-TISSUE TRANSGLUTAMINASE IGA EIA. This device is classified as a Autoantibodies, Endomysial(tissue Transglutaminase) (Class II - Special Controls, product code MVM).

Submitted by The Binding Site, Ltd. (Santa Monica, US). The FDA issued a Cleared decision on December 21, 1999, 57 days after receiving the submission on October 25, 1999.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K993612 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 25, 1999
Decision Date December 21, 1999
Days to Decision 57 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code MVM — Autoantibodies, Endomysial(tissue Transglutaminase)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660